IN8bio to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference Date/Time Tuesday, February 25, 2025, at 11:00 a.m. ET. Webcast Link https://journey.ct.events/view/acb6057e-9d9b-427e-b490-eaf85a5c2910 ...
Protagonist Therapeutics price target raised to $54 from $50 at H.C. Wainwright
H.C. Wainwright analyst Douglas Tsao raised the firm’s price target on Protagonist Therapeutics (PTGX) to $54 from $50 and keeps a Buy rating ...
Benitec Biopharma’s (BNTC) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of Benitec Biopharma (NASDAQ:BNTC – Free Report) in a research report sent ...
Ardelyx’s (ARDX) Neutral Rating Reiterated at HC Wainwright
HC Wainwright reiterated their neutral rating on shares of Ardelyx (NASDAQ:ARDX – Free Report) in a research report sent to ...
Morningstar27d
H.C. Wainwright & Co. Is Once Again Ranked #1 by PlacementTracker
Number 1 Investment Bank for Confidentially Marketed Public Offerings, Registered Direct, Private Placement, and At-the-Market (ATM) Offerings H.C. Wainwright & Co., LLC, announced its #1 Ranking ...
Investing6d
H.C. WAINWRIGHT MAINTAINS BUY RATING ON OKYO PHARMA STOCK
On Tuesday, H.C. Wainwright reaffirmed a positive outlook on OKYO Pharma Ltd. (NASDAQ: OKYO), maintaining a Buy rating and a $7.00 price target. Currently trading at $1.10, with a market ...
Business Wire27d
H.C. Wainwright & Co. Is Once Again Ranked #1 by PlacementTracker
NEW YORK--(BUSINESS WIRE)--H.C. Wainwright & Co., LLC, announced its #1 Ranking by transaction volume for the calendar year of 2024, maintaining the Firm’s top position for 11 consecutive years ...
Investing4d
H.C. Wainwright Maintains Buy on Precision BioSciences Stock
Thursday, H.C. Wainwright reaffirmed a Buy rating on Precision BioSciences Inc . (NASDAQ:DTIL) with a steady price target of $60.00, significantly above the current trading price of $5.65. The ...
Yahoo Finance27d
H.C. Wainwright & Co. Is Once Again Ranked #1 by PlacementTracker
In 2024 H.C. Wainwright also held the top position in PlacementTracker's Market League Tables for At-the-Market (ATM) Offerings representing 72 transactions. In addition to presently serving as ...
Yahoo Finance5d
Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
will participate in the H.C. Wainwright 3 rd Annual Cell Therapy Virtual Conference on Tuesday, February 25 at 10:30 am ET. (PRNewsfoto/CARISMA Therapeutics Inc.) An audio webcast of the event ...
Investing6d
H.C. Wainwright reiterates buy on Grace Therapeutics stock
On Tuesday, H.C. Wainwright reaffirmed its Buy rating and $12.00 price target for Grace Therapeutics (NASDAQ:GRCE), which currently trades at $3.45 with a market cap of $35 million. According to ...
Nasdaq5d
Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
will participate in the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference on Tuesday, February 25 at 10:30 am ET. An audio webcast of the event will be available on the Company's ...